CONCORD, N.H. A former Insys Therapeutics Inc sales representative now married to the drugmaker's ex-CEO said on Wednesday she arranged to have a physician assistant in New Hampshire receive kickbacks to prescribe patients its addictive fentanyl spray.
A Pennsylvania-based hospital system and its chief executive
have agreed to pay $12.5 million to resolve allegations that
they engaged in a scheme to artificially inflate reimbursements
from federal healthcare programs for orthopedic surgeries.
A federal jury in Delaware has ordered medical device maker
Edwards Lifesciences Corp to pay $35 million after finding a
heart valve replacement system it makes infringes a patent held
by rival Boston Scientific Corp.
A Nevada doctor has pleaded guilty to illegally distributing
a fentanyl-based pain spray made by Insys Therapeutics Inc that
was meant for cancer patients to a state court judge who did not
have the disease and later died of an overdose after using the
Dec 12 A former physician assistant is set to
face trial in New Hampshire on Wednesday over charges he
accepted kickbacks from Insys Therapeutics Inc to
prescribe a highly addictive fentanyl spray the drugmaker
Target Corp will pay $3 million to resolve claims that it
improperly billed Massachusetts' Medicaid program for
unauthorized automatic prescription refills, the state's
attorney general said on Tuesday.
An Olympus Corp subsidiary pleaded guilty on Monday and agreed to pay $85 million to resolve charges that it failed to file reports with U.S. regulators regarding infections connected to its duodenoscopes while continuing to sell the medical devices used to view the gastrointestinal tract.
The U.S. Federal Trade Commission on Tuesday will urge a
federal appeals court to overturn the dismissal of its lawsuit
accusing a unit of drugmaker Shire PLC of violating antitrust
laws, saying the lower court's ruling threatens its enforcement
A federal judge in Philadelphia has rejected Johnson &
Johnson's bid to dismiss class action lawsuits by retailers and
insurers claiming the drugmaker conducted an anticompetitive
scheme to shield its blockbuster rheumatoid arthritis drug
Remicade from competition.
A former regional sales director at Insys Therapeutics Inc
charged with five other former executives and managers with
conspiring to bribe doctors to prescribe an addictive opioid,
and set to be tried with them in January, is seeking a separate